Hormonal Therapy for mCSPC: With So Many Options, How Does One Choose?

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer”, Dr. Shore from the Carolina Urologic Research […]

ASCO20 Virtual: Hormonal Therapy for mCSPC: With So Many Options, How Does One Choose?

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer”, Dr. Shore from the Carolina Urologic Research […]

Recent Advances in Nuclear Medicine Theranostics for Cancer: New Isotopes and Targets

(UroToday.com) The American Society of Clinical Oncologist’s (ASCO) 2020 virtual education program featured a session on recent advances in nuclear medicine theranostics for cancer, including Michael Hofman discussing new isotopes and targets. Dr. Hofman notes that there are several U.S. Food and Drug Administration (FDA) approved theranostic agents, as summarized in the following table: According […]

ASCO20 Virtual: Recent Advances in Nuclear Medicine Theranostics for Cancer: New Isotopes and Targets

(UroToday.com) The American Society of Clinical Oncologists (ASCO) 2020 virtual education program featured a session on recent advances in nuclear medicine theranostics for cancer, including Michael Hofman discussing new isotopes and targets. Dr. Hofman notes that there are several U.S. Food and Drug Administration (FDA) approved theranostic agents, as summarized in the following table: According […]

Emerging Systemic Treatment Strategies for High-Risk, Clinically Localized Prostate Cancer

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Rana McKay, MD, from Moores Cancer Center at University of […]

ASCO20 Virtual: Emerging Systemic Treatment Strategies for High-Risk, Clinically Localized Prostate Cancer

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Rana McKay, MD, from Moores Cancer Center at University of […]

Choosing a Primary Treatment Modality for High-Risk Localized Prostate Cancer

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Kelvin A. Moses, MD, Ph.D., from Vanderbilt University School of Medicine presented […]

ASCO20 Virtual: Choosing a Primary Treatment Modality for High-Risk Localized Prostate Cancer

(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Kelvin A. Moses, MD, Ph.D., from Vanderbilt University School of Medicine presented […]

X